Girls with cystic fibrosis (CF) under the age of six have higher levels of a tiny RNA molecule, miR-885-5p,…
Articles by Patricia Inácio, PhD
Developing a way to destroy persister cells — bacterial cells that enter a dormant phase and are able to resist…
A project aimed at personalized medicine based on the use of organoids, or “mini-organs,” from cystic fibrosis (CF) patients…
Cystic fibrosis carriers — individuals who have certain genetic mutations in one of the copies of the CFTR…
Genetic variations that lower the expression levels of a gene called RNF5 may explain why some people with cystic fibrosis…
Babies diagnosed with cystic fibrosis (CF) through newborn bloodspot screening show better lung function, can better stave off infection…
Treatment with Kalydeco (ivacaftor) alone improved lung function and quality of life in a cystic fibrosis patient carrying both…
Two new alterations in the CFTR gene, leading to a deficient CFTR protein and consequently causing cystic fibrosis (CF),…
The European Medicines Agency (EMA) has validated Vertex Pharmaceuticals’ application seeking approval for its triple combination —…
When Vertex Pharmaceuticals’ cystic fibrosis (CF) therapy Trikafta was approved recently by the U.S. Food and Drug…